Author Question: In the prevention of family violence, Gelles and Straus argue that policies and programs must be ... (Read 71 times)

Cooldude101

  • Hero Member
  • *****
  • Posts: 557
In the prevention of family violence, Gelles and Straus argue that policies and programs must be directed primarily toward
 
  A) counseling and therapy for the abusive family member.
  B) cultural norms and values that support violence.
  C) educating parents about the need for strict discipline, including corporal punishment, in rearing their children.
  D) any and all of the above.

Question 2

Single parents are more likely to abuse children than are two-parent families, but there are no significant differences by race, ethnicity, or social class.
 
  Indicate whether the statement is true or false



atrochim

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

F



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library